Product Specifications
Below are the key product attributes and specifications that provide detailed information about this item:
Product Overview
The Abbott - 02k4421 - Immunoassay Reagent Architect Ca 15-3 is designed for use with the Architect Ci8200 Analyzer, providing reliable and accurate quantitative determination of CA 15-3 antigen levels in human serum and plasma. This reagent is essential for monitoring breast cancer progression and treatment response, offering high precision and consistency in clinical diagnostics.
Key Features:
- 400 tests per kit, ensuring cost-effective and efficient laboratory testing.
- Compatible with Architect Ci8200 Analyzer, delivering seamless integration and automated processing.
- Quantitative measurement of CA 15-3, aiding in the assessment of breast cancer recurrence and therapy monitoring.
- High sensitivity and specificity, ensuring accurate and reproducible results.
- Ready-to-use formulation, minimizing preparation time and reducing handling errors.
Specifications:
- Test Type: Immunoassay (CMIA - Chemiluminescent Microparticle Immunoassay).
- Sample Type: Human serum or plasma.
- Pack Size: 400 tests.
- Storage: Store at 2°C to 8°C; protect from light.
- Shelf Life: Refer to expiration date on packaging.
Suggested Use:
This reagent is ideal for clinical laboratories and diagnostic centers performing CA 15-3 testing for breast cancer management. It should be used according to the Architect Ci8200 system protocols, ensuring proper calibration and quality control for optimal performance. Regular monitoring of CA 15-3 levels assists in evaluating treatment efficacy and detecting disease recurrence.
